全文获取类型
收费全文 | 7648篇 |
免费 | 687篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 211篇 |
妇产科学 | 105篇 |
基础医学 | 885篇 |
口腔科学 | 163篇 |
临床医学 | 861篇 |
内科学 | 1505篇 |
皮肤病学 | 99篇 |
神经病学 | 444篇 |
特种医学 | 549篇 |
外科学 | 1027篇 |
综合类 | 186篇 |
一般理论 | 1篇 |
预防医学 | 860篇 |
眼科学 | 99篇 |
药学 | 596篇 |
1篇 | |
中国医学 | 4篇 |
肿瘤学 | 707篇 |
出版年
2023年 | 47篇 |
2021年 | 110篇 |
2020年 | 72篇 |
2019年 | 105篇 |
2018年 | 139篇 |
2017年 | 104篇 |
2016年 | 129篇 |
2015年 | 117篇 |
2014年 | 178篇 |
2013年 | 254篇 |
2012年 | 366篇 |
2011年 | 347篇 |
2010年 | 217篇 |
2009年 | 182篇 |
2008年 | 322篇 |
2007年 | 368篇 |
2006年 | 331篇 |
2005年 | 297篇 |
2004年 | 295篇 |
2003年 | 275篇 |
2002年 | 270篇 |
2001年 | 266篇 |
2000年 | 280篇 |
1999年 | 207篇 |
1998年 | 109篇 |
1997年 | 94篇 |
1996年 | 80篇 |
1995年 | 106篇 |
1994年 | 91篇 |
1993年 | 96篇 |
1992年 | 188篇 |
1991年 | 166篇 |
1990年 | 162篇 |
1989年 | 153篇 |
1988年 | 189篇 |
1987年 | 172篇 |
1986年 | 128篇 |
1985年 | 150篇 |
1984年 | 104篇 |
1983年 | 104篇 |
1982年 | 62篇 |
1981年 | 59篇 |
1980年 | 48篇 |
1979年 | 93篇 |
1978年 | 73篇 |
1977年 | 51篇 |
1976年 | 49篇 |
1974年 | 55篇 |
1973年 | 62篇 |
1970年 | 43篇 |
排序方式: 共有8357条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
Padmaja Yalamanchili Eric Wexler Megan Hayes Ming Yu Jody Bozek Mikhail Kagan Heike S. Radeke Michael Azure Ajay Purohit David S. Casebier Simon P. Robinson 《Journal of nuclear cardiology》2007,14(6):782-788
Background
BMS-747158-02 is a novel fluorine 18-labeled pyridazinone derivative designed for cardiac imaging. The uptake and retention
mechanisms of F-18 BMS-747158-02 in cardiac myocytes were studied in vitro, and the biodistribution of F-18 BMS-747158-02
was studied in vivo in mice.
Methods and Results
Fluorine 19 BMS-747158-01 inhibited mitochondrial complex I (MC-I) in bovine heart submitochondrial particles with an IC50 of 16.6±3 nmol/L that was comparable to the reference inhibitors of MC-1, rotenone, pyridaben, and deguelin (IC50 of 18.2±6.7 nmol/L, 19.8±2.6 nmol/L, and 23.1±1.5 nmol/L, respectively). F-18 BMS-747158-02 had high uptake in monolayers
of neonatal rat cardiomyocytes (10.3%±0.7% of incubated drug at 60 minutes) that was inhibited by 200 nmol/L of rotenone (91%±2%)
and deguelin (89%±3%). In contrast, an inactive pyridaben analog, P-0 (IC50 value>4 μmol/L in MC-1 assay), did not inhibit the binding of F-18 BMS-747158-02 in cardiomyocytes. Uptake and washout kinetics
for F-18 BMS-747158-02 in rat cardiomyocytes indicated that the time to half-maximal (t1/2) uptake was very rapid (approximately 35 seconds), and washout t1/2 for efflux of F-18 BMS-747158-02 was greater than 120 minutes. In vivo biodistribution studies in mice showed that F-18 BMS-747158-02
had substatial myocardial uptake (9.5%±0.5% of injected dose per gram) at 60 minutes and heart-to-lung and heart-to-liver
ratios of 14.1±2.5 and 8.3±0.5, respectively. Positron emission tomography imaging in the mouse allowed clear cardiac visualization
and demonstrated sustained myocardial uptake through 55 minutes.
Conclusions
F-18 BMS-747158-02 is a novel positron emission tomography cardiac tracer targeting MC-I in cardiomyocytes with rapid uptake
and slow washout. These characteristics allow fast and sustained accumulation in the heart. 相似文献
15.
Alfred E Buxton Hugh Calkins David J Callans John P DiMarco John D Fisher H Leon Greene David E Haines David L Hayes Paul A Heidenreich John M Miller Athena Poppas Eric N Prystowsky Mark H Schoenfeld Peter J Zimetbaum Paul A Heidenreich David C Goff Frederick L Grover David J Malenka Eric D Peterson Martha J Radford Rita F Redberg 《Journal of the American College of Cardiology》2006,48(11):2360-2396
16.
V V Joshi A B Cantor G Altshuler E W Larkin J S Neill J J Shuster C T Holbrook F A Hayes R Nitschke M H Duncan 《Cancer》1992,69(8):2197-2211
Histologic sections (minimum of four sections per patient) from 211 patients with neuroblastoma were reviewed. The tumors were resected before therapy, which was standardized according to age and stage. Low mitotic rate (MR) (less than or equal to ten per ten high-power fields) and calcification emerged as the most significant prognostic features after statistical analysis by stepwise log-rank tests (P less than 0.0001 and P = 0.0065, respectively). Histologic Grades 1, 2, and 3 were defined on the basis of the presence of both, any one, or none of these two prognostic features, respectively (Grade 3 had absence of low MR, i.e., these tumors had high MR [greater than ten per ten high-power fields]). Statistically significant differences in survival were observed in the grades after adjusting for age and stage (P less than 0.001). The degree of differentiation, although significant by itself, was no longer significant after adjusting for the grades. Age groups (less than or equal to 1 versus greater than 1 year of age), which also emerged as an independent prognostic feature (P less than 0.001), were linked with the grades to define two risk groups as follows: (1) a low-risk (LR) group consisting of patients in both age groups with Grade 1 tumors and patients 1 year of age or younger with Grade 2 tumors and (2) a high-risk (HR) group consisting of patients older than 1 year of age with Grade 2 tumors and patients in both age groups with Grade 3 tumors. The difference in survival between LR (160 cases) and HR groups (51 cases) was statistically significant (P less than 0.001). Concordance between these LR and HR groups and the Shimada classification was observed in 84% of cases. The new histologic grading system has the following advantages: (1) use of familiar terminology and histologic features in the grading system and (2) relative ease of assessment because the degree of differentiation does not need to be determined. The grading system should be tested on a new data set with an appropriate histologic sample of similar size to confirm these results. 相似文献
17.
18.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
19.
James E Hayes 《Emergency medicine Australasia : EMA》1997,9(2):123-135
Cardiac tamponade is a life threatening condition that results from accumulation of intrapericardial fluid or air, leading to impaired cardiac filling and consequent reduction of cardiac output. There are many causes, best categorised as non-traumatic and traumatic. The diagnosis is most commonly made on echocardiographic evidence of effusion together with the clinical findings. Clinical findings, however, are non-specific and often unreliable especially early in the process of cardiac tamponade. A high index of suspicion must therefore be maintained. Definitive treatment consists of pericardiocentesis or surgical drainage, the choice of which will depend upon the urgency of the situation, the aetiology and the available facilities and personnel. 相似文献
20.
CONTEXT: The limited information available on the oral health status of rural children in the United States makes it difficult to devise policy strategies to address perceived problems. PURPOSE: To document the oral health status and dental care utilization of US children by place of residence, METHODS: Data from National Health Interview Surveys for 1995, 1997, and 1998, and from the third National Health and Nutrition Examination Survey (1988-1994) were analyzed. FINDINGS: Children residing in rural areas were more likely to be uninsured for dental care than were children from urban areas (41.1% versus 34.7%). A greater percentage of rural than urban children reported unmet dental needs (7.5% versus 5.6%); there was no difference in self-reported poor dental status. Urban children were more likely than rural children to have visited the dentist in the past year (73.6% versus 69.9%) and were also more likely to be regular users of dental care (61.7% versus 51.4%). Differences in percentage of rural and urban children with caries lesions and caries experience were not significant. CONCLUSIONS: Children residing in rural areas have less access to and utilization of dental care compared to children residing in urban areas. Moreover, poor rural children display less utilization of dental services than poor urban children. Differences in the sum of decayed and filled primary teeth and the sum of decayed, missing, and filled permanent teeth were not significant. 相似文献